Viewing Study NCT05488132


Ignite Creation Date: 2025-12-24 @ 9:30 PM
Ignite Modification Date: 2026-02-22 @ 7:23 PM
Study NCT ID: NCT05488132
Status: UNKNOWN
Last Update Posted: 2022-08-04
First Post: 2022-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Administration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)
Sponsor: Xuzhou Medical University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia Refractory View
None Acute Myeloid Leukemia, in Relapse View
Keywords: